Open AccessIntralesional Measles-Mumps-Rubella Vaccine for Genital Warts
Author(s) -
Al-Mu'tasim Al-Qassabi,
Fahad Al-Farsi
Publication year - 2022
Publication title -
sultan qaboos university medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.258
H-Index - 27
eISSN - 2075-0528
pISSN - 2075-051X
DOI - 10.18295/squmj.6.2021.093
Subject(s) - medicine , genital warts , rubella , measles mumps rubella vaccine , measles , dermatology , common warts , rubella vaccine , virology , mmr vaccine , immunology , asymptomatic , vaccination , human papillomavirus , human immunodeficiency virus (hiv) , pathology , syphilis
Genital warts are caused by several strains of Human Papilloma Viruses (HPVs). Although asymptomatic in most cases, they can be psychologically and physically distressing for patients. Recently, Intralesional immunotherapy by different antigens like Bacille Calmette–Guerin vaccine, candida antigen, and measles, mumps, and rubella (MMR) vaccine has shown promising efficacy in the treatment of warts. Here we report two cases in Omani males who presented to the dermatology clinic at Barka Poly clinic with recalcitrant genital warts that resolved completely with intralesional injection of MMR vaccine.
Keywords: Genital Warts; immunotherapy; Measles-Mumps-Rubella Vaccine; Venereal Warts; Oman